Liquidia Corporation (LQDA) NASDAQ

Currency In USD

Liquidia Corporation

Address

419 Davis Drive

Morrisville, NC 27560

United States of America (the)

Phone

919 328 4400

Website

https://www.liquidia.com

Sector

Healthcare

Industry

Biotechnology

Employees

170

First IPO Date

July 26, 2018

Key Executives

Name	Title	Pay	Year Born
Roger A. Jeffs	Chief Executive Officer & Director	2.12M	1962
Scott Moomaw	Chief Commercial Officer	980,961	1971
Rajeev Saggar	Chief Medical Officer	1.17M	1975
Russell Schundler	General Counsel & Corporate Secretary	1.17M	1976
Michael Kaseta	Chief Operating Officer & Chief Financial Officer	1.41M	1976
Harold Alterson	Senior Vice President of Quality	0	N/A
Dana Boyle	Chief Accounting Officer	0	1985
Michael Hunter	Senior Vice President of Manufacturing Operations	0	N/A
Matt Snow	Senior Vice President of Sales	0	N/A
Jason Adair	Chief Business Officer	0	1972
Frank Bartolini	Senior Vice President of Market Access	0	N/A
Beth-Anne Lang	Senior Vice President of Global Regulatory Affairs	0	N/A
Michael Post	Senior Vice President of Marketing	0	N/A
Sarah Krepp SPHR	Chief Human Resources Officer	0	1982
Gareth Gwyn	Senior Vice President of Medical Affairs	0	N/A
Christian Perez Font	Senior Vice President, Chief Compliance Officer & Associate General Counsel	0	N/A

Description

Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.